上海和辉光电股份有限公司 募集资金管理制度 上海和辉光电股份有限公司 募集资金管理制度 第一章 总则 第一条 为进一步完善上海和辉光电股份有限公司（以下简称"公司"）的法 人治理结构，规范公司募集资金的管理和运用，以维护股东的合法利益，根据《中 华人民共和国公司法》（以下简称"《公司法》"） 、《中华人民共和国证券法》（以 下简称"《证券法》"）、 《上市公司募集资金监管规则》 《上海证券交易所科创板股 票上市规则》 （以下简称"《上市规则》"）、 《上海证券交易所科创板上市公司自律 监管指引第 1 号——规范运作》 （以下简称"《规范运作》"）等法律、法规、规范 性文件和《上海和辉光电股份有限公司章程》 （以下简称"《公司章程》"）的规定， 结合公司实际情况，特制定本制度。 第二条 本制度所称募集资金，是指公司通过发行股票或者其他具有股权性 质的证券，向投资者募集并用于特定用途的资金，但不包括公司实施股权激励计 划募集的资金。 第三条 公司必须按发行申请文件中承诺的募集资金使用计划，股东会、董 事会的决议及相关审批程序使用募集资金，并按要求披露募集资金的使用情况。 第四条 本制度旨在建立募集资金存放、使用和 ...

Core Points - The company, Shenzhen Daotong Technology Co., Ltd., has utilized its own funds to pay for investment projects and plans to replace these with raised funds in accordance with regulatory requirements [1][4][6] Fundraising Overview - The company issued 12.8 million convertible bonds at a price of 100 RMB each, raising a total of 128 million RMB, with net proceeds amounting to approximately 126.2 million RMB after deducting underwriting fees [1][2] - The funds raised are designated for the construction of the Daotong Technology R&D Center and the development of new intelligent maintenance and new energy solutions, with a total project investment of approximately 210.2 million RMB [2][3] Use of Own Funds - The company has opted to use its own funds for certain expenditures related to the investment projects due to regulatory requirements regarding salary payments, which necessitate using basic or general deposit accounts rather than the dedicated fundraising account [2][3] - The company will subsequently replace the amount spent from its own funds with an equivalent amount from the raised funds, ensuring compliance with the principle of dedicated use of raised funds [3][4] Impact on Operations - The decision to use self-funds for project expenditures is expected to enhance operational efficiency and ensure the smooth progress of investment projects without affecting the normal implementation of these projects [3][4] Approval Process - The board of directors and the supervisory board of the company approved the use of self-funds and the subsequent replacement with raised funds, confirming that the necessary approval procedures were followed and that there is no change in the intended use of the raised funds [4][5]

Fundraising Overview - The company raised a total of RMB 3,549,753,292.26 from the public offering of 108,588,354 shares at a price of RMB 32.69 per share, with a net amount of RMB 3,471,727,753.82 after deducting issuance costs [1][2] - As of June 30, 2025, the remaining balance of the raised funds is RMB 965,810,000.00, with a total of RMB 2,471,903,602.72 used [1][2] Fund Management - The company has established a management method for the raised funds, ensuring compliance with relevant laws and regulations [1][2] - As of June 30, 2025, the total amount of idle raised funds used for cash management is RMB 965,810,000.00, with specific investments in structured deposits and seven-day notice deposits [2][5] Investment Projects - The company has not changed the use of the raised funds or transferred any investment projects during the reporting period [2][4] - The company has adjusted the expected completion dates for several EDA tool projects due to external market conditions, with new completion dates set for December 31, 2024, and December 31, 2025 [3][4] Cash Management - The company approved the use of up to RMB 1.2 billion of idle raised funds for cash management, with a balance of RMB 965,810,000.00 as of June 30, 2025 [2][5] - The cash management products include structured deposits with varying interest rates and seven-day notice deposits [2][5] Compliance and Reporting - The company confirms that the disclosure of the use of raised funds aligns with actual usage, with no violations reported [2][6] - There are no significant changes in the feasibility of the investment projects, and the company continues to adhere to its planned investment strategies [4][6]

深圳市必易微电子股份有限公司 募集资金管理办法 深圳市必易微电子股份有限公司 募集资金管理办法 第一章 总则 第一条 为了规范深圳市必易微电子股份有限公司（以下简称"公司"）募集 资金的管理和使用，切实保护投资者的权益，依照《中华人民共和国公司法》（以 下简称"《公司法》"）、《中华人民共和国证券法》（以下简称"《证券法》"）、 《上市公司募集资金监管规则》《上海证券交易所科创板上市公司自律监管指引第 公司章程》（以下简称"《公司章程》"）的规定，并结合公司实际情况，制定本 办法。 第二条 本办法所称募集资金，是指公司通过发行股票或者其他具有股权性质 的证券，向投资者募集并用于特定用途的资金，不包括公司为实施股权激励计划募 集的资金。 第三条 公司董事会应当持续关注募集资金存放、管理和使用情况，有效防范 投资风险，提高募集资金使用效益。 第四条 募集资金投资项目通过公司子公司或公司控制的其他企业实施的，公 司应当采取适当措施保证该子公司或被控制的其他企业遵守本办法的各项规定。 募集资金投资项目采用与他人组建合资公司方式建设时，该合资公司应当参考 本办法制定相应的募集资金管理办法。 第五条 公司的董事和高级管理 ...

德龙汇能集团股份有限公司 DELONG COMPOSITE ENERGY GROUP CO., LTD 募集资金管理办法 ［本制度尚需提交公司 2025 年第三次临时股东大会审议］ 第一章 总则 第一条 为了规范德龙汇能集团股份有限公司（以下简称 "公司"）募集资金的管理和运用，切实保护投资者的利益， 依据《中华人民共和国公司法》《中华人民共和国证券法》《上 市公司募集资金监管规则》《深圳证券交易所股票上市规则》《深 圳证券交易所主板上市公司规范运作指引》等法律、法规及规 范性文件的规定，结合公司实际情况，制定本办法。 第二条 本办法所称募集资金是指公司通过发行证券股 票或者其他具有股权性质的证券，向投资者募集并用于特定 用途的资金，不包括公司为实施股权激励计划募集的资金。 本办法所称超募资金，是指实际募集资金净额超过计划 募集资金金额的部分 第三条 公司募集资金应当专款专用。公司使用募集资金应 当符合国家产业政策和相关法律法规，践行可持续发展理念，履 行社会责任，原则上应当用于主营业务，有利于增强公司竞争能 力和创新能力。 第四条 公司应当审慎使用募集资金，保证募集资金 的使用与发行申请文件的承诺相一致，不 ...

Summary of Key Points Core Viewpoint The report provides a detailed account of the fundraising activities and the actual usage of the raised funds by Guangzhou Baiyunshan Pharmaceutical Group Co., Ltd. for the first half of 2025, ensuring compliance with regulatory requirements and transparency in financial management. Group 1: Fundraising Overview - The company raised a total of approximately 7.89 billion RMB through a non-public offering of 334,711,699 shares at a price of 23.56 RMB per share, with a net amount of approximately 7.86 billion RMB after deducting issuance costs [1][2]. - The funds were verified by an accounting firm, and the report includes a verification report number [1]. Group 2: Fund Usage and Current Balance - As of June 30, 2025, the total amount of raised funds used was approximately 766,170.29 million RMB, with a remaining balance of approximately 41,839.21 million RMB in dedicated accounts [2][3]. - The company has established dedicated accounts at various banks to manage the raised funds, ensuring proper oversight and compliance with regulations [3][4]. Group 3: Fund Management and Compliance - The company has implemented a fundraising management method to regulate the use of raised funds and protect investor interests, which was approved by the shareholders [2][4]. - There were no instances of using idle funds for temporary working capital or investing in financial products during the reporting period [6][12]. Group 4: Project Investment and Changes - The total investment in fundraising projects amounted to approximately 766,170.29 million RMB, including pre-investments from self-raised funds [6][10]. - The company has made changes to the use of funds for specific projects, including reallocating funds for the acquisition of trademarks and construction projects, with all changes approved by the board and disclosed appropriately [8][9][10]. Group 5: Project Status and Future Plans - Several projects funded by the raised capital are either completed or in the operational phase, with ongoing assessments of their financial returns [12][14]. - The company has not reported any significant delays or changes in the feasibility of the projects funded by the raised capital [12][14].

Core Points - The document outlines the fundraising management system of Guangzhou Weili Medical Equipment Co., Ltd, aiming to regulate the use and management of raised funds, enhance efficiency, and protect investors' rights [1][2][3] Group 1: General Principles - The system applies to funds raised through stock issuance or other equity-like securities, excluding funds raised for equity incentive plans [1] - Funds must be used specifically for designated purposes, aligning with national industrial policies and sustainable development principles [1][2] - The board of directors is responsible for monitoring the management and usage of raised funds to mitigate investment risks [2][3] Group 2: Fund Storage - The company must open a special account for raised funds in a commercial bank, ensuring that these funds are not mixed with other funds [9][10] - If the company has multiple financings, separate accounts must be established for each [10] - A tripartite supervision agreement must be signed with the underwriter or independent financial advisor and the bank within one month of fund receipt [12][13] Group 3: Fund Usage - Funds must be used according to the usage plan outlined in the issuance application documents [13][14] - If significant changes occur affecting the investment project, the company must reassess the project's feasibility and disclose any adjustments [14][15] - The company is prohibited from using raised funds for financial investments or providing funds to controlling shareholders or related parties [6][7] Group 4: Changes in Fund Allocation - Any changes in the use of raised funds require board approval and must be disclosed to shareholders [32][33] - The company must ensure that new investment projects enhance competitiveness and innovation capabilities [34][35] - If funds are to be used for projects outside the original plan, a detailed disclosure of reasons and implications is required [36][37] Group 5: Management and Supervision - The finance department must maintain a detailed record of fund usage, and internal audits should occur at least biannually [38][39] - The underwriter or independent financial advisor must conduct regular oversight and report any irregularities [40][41] - Annual audits must include a verification report on the management and usage of raised funds [42][43]

Core Points - The company establishes a system to improve the management and usage of raised funds, ensuring compliance with relevant laws and regulations [1][2][3] - The company must disclose the actual usage of raised funds accurately and completely, and announce any significant impacts on investment plans [2][3] - The company is prohibited from changing the intended use of raised funds without proper approval and disclosure [3][4] Fund Management - The company must establish internal controls for the management and usage of raised funds, including approval processes and risk control measures [2][5] - Raised funds should be stored in a special account approved by the board and cannot be used for non-designated purposes [9][10] - The company can temporarily use idle raised funds for cash management, provided it does not affect the normal investment plans [6][7] Investment Projects - The company must use raised funds for specific projects as outlined in the prospectus and cannot change the project without board approval [3][4] - If there are changes in the investment project, the company must provide justifications and seek necessary approvals [11][12] - The company is required to report on the progress of investment projects and any deviations from the planned usage of raised funds [13][14] Oversight and Reporting - The company must conduct regular audits of the management and usage of raised funds and report findings to the board [5][13] - The sponsor institution is responsible for ongoing supervision of the company's fund management and must report any irregularities [13][14] - The company must disclose any significant changes in the financial status of cash management products used for idle funds [7][8]

Meeting Overview - The second meeting of the Supervisory Board of Shanghai Huhui Optoelectronics Co., Ltd. was held on August 14, 2025, with all 7 supervisors present, confirming the legality and validity of the meeting procedures [1] - The meeting was chaired by Mr. Ying Xiaoming, and the notice was sent to all supervisors on August 4, 2025 [1] Financial Reporting - The preparation and review process of the 2025 semi-annual report complies with relevant laws and regulations, accurately reflecting the company's financial status and operational results [1] - The report contains no false records, misleading statements, or significant omissions [1] Fund Management - The management and actual use of raised funds for the first half of 2025 comply with legal regulations, with no violations or misappropriations reported [2] - The special report on the management and use of raised funds accurately reflects the actual situation [2] Fund Replacement - The company plans to use its own funds to pay for project investments and will subsequently replace them with raised funds, which is in line with regulatory requirements [3] - This approach aims to enhance operational management efficiency without harming shareholder interests [3] Cash Management - The company intends to use a maximum of RMB 300 million of temporarily idle raised funds for cash management within 12 months, ensuring it does not conflict with investment project implementations [4] - This decision is expected to improve fund utilization efficiency and yield good returns [4] Supervisory Board Changes - The company plans to abolish the Supervisory Board, transferring its powers to the Audit Committee of the Board of Directors, pending shareholder approval [5] - Corresponding amendments to the company's articles of association and meeting rules have been drafted [5]

Group 1 - The board of directors of Wuhan Guangting Information Technology Co., Ltd. held its seventh meeting of the fourth session on August 15, 2025, with all nine directors present, ensuring compliance with legal and regulatory requirements [1] - The board approved the "2025 Semi-Annual Report" and its summary, confirming that the report accurately reflects the company's financial status and operational results without any false statements or omissions [2][3] - The board also approved the "Special Report on the Storage and Use of Raised Funds for the First Half of 2025," affirming that the disclosure of the use of raised funds aligns with actual usage and complies with relevant regulations [2][3] Group 2 - The board agreed to use up to RMB 900 million of temporarily idle raised funds for cash management, ensuring that this does not affect the investment projects or normal operations, with a validity period of 12 months [3]